Studies on dipeptidyl(amino)peptidase IV (glycylproline-naphthylamidase) in blood vessels.

DOD

Discussions

Biomedical Jobmarket

News

DOD Alert

Edit DOD

ACCOUNT

Forgotten Password?


Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > GLP-1 > Effectivity of GLP-1 in Therapy > Degradation by Dipeptidyl Peptidase IV > Journal Article

(Journal Article): Studies on dipeptidyl(amino)peptidase IV (glycylproline-naphthylamidase) in blood vessels.

Lojda Z

IN: Histochemistry 1979; 59:153-166

Fulltext: HTML

ABSTRACT: n.a.

TYPE OF PUBLICATION: Original article

Articles citing this article:

Deacon CF, Johnsen AH, Holst JJ. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 1995. 80: 952-957.
» Diabetes OD » Disease Management » T2DM » Metabolic Control » Anti-Hyperglycemic and Anti-Ap... » Incretin Hormones » GLP-1 » Effectivity of GLP-1 in Therap... » Degradation by Dipeptidyl Pept... » Journal Article

Respond on this Journal Article! Hint: Your Response should directly apply to *Studies on dipeptidyl(amino)peptidase IV (glycylproline-naphthylamidase) in blood vessels.. Please check, if this context applies best to your contribution. Otherwise click HERE* to change to the appropriate subject area. The actual subject area is Degradation by Dipeptidyl Peptidase IV.

About DOD | Advertising Information | Support The Project | DOD alert | Become Editor